GaldermaReceivesU.S.FDAApprovalforRestylaneContourfortheCorrectionofTempleHollowing
===2026/3/23 18:43:07===
red treatment responders at three months and over 85% were considered treatment responders up to 18 months after initial treatment1,2
Clinical investigators rated 100% of patients as having improved from baseline at three months, with 98% at six months and 89% at 18 months1,2
Patient satisfaction:
Over 70% of patients felt they looked younger, less tired, and more refreshed 18 months after treatment, and 85% felt their temples looked natural at Month 181,2
Over 84% of patients were satisfied with their temples for a full 18 months as assessed by the FACE-Q patient-reported outcome tool1,2
99% of investigators felt the results were natural looking three months after treatment1,2
All treatment-related adverse events were mild to moderate, with no serious events1,2
Safety:
“This approval for Restylane Contour with an innovat
=*=*=*=*=*=
当前为第5/15页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页